Publications
-
Molecular framework for response to imatinib mesylate in systemic sclerosis.
Chung L,
Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL, Whitfield ML, Chang HY, Robinson WH.
Arthritis Rheum.
2009;
60
(2):
584-91
-
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.
Hueber W,
Tomooka BH, Batliwalla F, Li W, Monach PA, Tibshirani RJ, Van Vollenhoven RF, Lampa J, Saito K, Tanaka Y, Genovese MC, Klareskog L, Gregersen PK, Robinson WH.
Arthritis Res Ther.
2009;
11
(3):
R76
-
Tyrosine kinases as targets for the treatment of rheumatoid arthritis.
D'Aura Swanson C,
Paniagua RT, Lindstrom TM, Robinson WH.
Nat Rev Rheumatol.
2009;
5
(6):
317-24
-
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Han MH,
Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L.
Nature.
2008;
451
(7182):
1076-81
-
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
Paniagua RT,
Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP, Tomooka BH, Thomas FM, Song JJ, Goodman SB, Lee DM, Genovese MC, Utz PJ, Steinman L, Robinson WH.
J Clin Invest.
2006;
116
(10):
2633-42
-
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Kanter JL,
Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH.
Nat Med.
2006;
12
(1):
138-43
-
Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin.
Coffey GP,
Rajapaksa R, Liu R, Sharpe O, Kuo CC, Krauss SW, Sagi Y, Davis RE, Staudt LM, Sharman JP, Robinson WH, Levy S.
J Cell Sci.
2009;
122
(Pt 17):
3137-44
-
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
Britschgi M,
Olin CE, Johns HT, Takeda-Uchimura Y, LeMieux MC, Rufibach K, Rajadas J, Zhang H, Tomooka B, Robinson WH, Clark CM, Fagan AM, Galasko DR, Holtzman DM, Jutel M, Kaye JA, Lemere CA, Leszek J, Li G, Peskind ER, Quinn JF, Yesavage JA, Ghiso JA, Wyss-Coray T.
Proc Natl Acad Sci U S A.
2009;
106
(29):
12145-50
-
Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis.
Sharif SA,
Du X, Myles T, Song JJ, Price E, Lee DM, Goodman SB, Nagashima M, Morser J, Robinson WH, Leung LL.
Arthritis Rheum.
2009;
60
(10):
2902-2912
-
Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination.
Kidd BA,
Ho PP, Sharpe O, Zhao X, Tomooka BH, Kanter JL, Steinman L, Robinson WH.
Arthritis Res Ther.
2008;
10
(5):
R119
-
Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
Leung LL,
Myles T, Nishimura T, Song JJ, Robinson WH.
Mol Immunol.
2008;
45
(16):
4080-3
-
Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance.
Shachaf CM,
Gentles AJ, Elchuri S, Sahoo D, Soen Y, Sharpe O, Perez OD, Chang M, Mitchel D, Robinson WH, Dill D, Nolan GP, Plevritis SK, Felsher DW.
Cancer Res.
2008;
68
(13):
5132-42
-
Imatinib for the treatment of rheumatic diseases.
Paniagua RT,
Robinson WH.
Nat Clin Pract Rheumatol.
2007;
3
(4):
190-1
-
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.
Hueber W,
Tomooka BH, Zhao X, Kidd BA, Drijfhout JW, Fries JF, van Venrooij WJ, Metzger AL, Genovese MC, Robinson WH.
Ann Rheum Dis.
2007;
66
(6):
712-9
-
Identification of biomarkers associated with the development of hepatocellular carcinoma in CuZn superoxide dismutase deficient mice.
Elchuri S,
Naeemuddin M, Sharpe O, Robinson WH, Huang TT.
Proteomics.
2007;
7
(12):
2121-9
-
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
Bar-Or A,
Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, Shi FD, Utz PJ, Valone F, Weiner L, Steinman L, Garren H.
Arch Neurol.
2007;
64
(10):
1407-15
-
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Ousman SS,
Tomooka BH, van Noort JM, Wawrousek EF, O'Connor KC, Hafler DA, Sobel RA, Robinson WH, Steinman L.
Nature.
2007;
448
(7152):
474-9
-
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.
Kuhn KA,
Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM.
J Clin Invest.
2006;
116
(4):
961-73
-
Proteomic biomarkers for autoimmune disease.
Hueber W,
Robinson WH.
Proteomics.
2006;
6
(14):
4100-5
-
Fluid supported lipid bilayers containing monosialoganglioside GM1: a QCM-D and FRAP study.
Weng KC,
Kanter JL, Robinson WH, Frank CW.
Colloids Surf B Biointerfaces.
2006;
50
(1):
76-84
-
Tolerizing DNA vaccines for autoimmune arthritis.
Ho PP,
Higgins JP, Kidd BA, Tomooka B, Digennaro C, Lee LY, de Vegvar HE, Steinman L, Robinson WH.
Autoimmunity.
2006;
39
(8):
675-82
-
Antigen arrays for antibody profiling.
Robinson WH,
Curr Opin Chem Biol.
2006;
10
(1):
67-72
-
Suppression of autoimmunity via microbial mimics of altered peptide ligands.
Steinman L,
Utz PJ, Robinson WH.
Curr Top Microbiol Immunol.
2005:
296
55-63
-
Antigen microarray profiling of autoantibodies in rheumatoid arthritis.
Hueber W,
Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, Sønderstrup G, Monach P, Drijfhout JW, van Venrooij WJ, Utz PJ, Genovese MC, Robinson WH.
Arthritis Rheum.
2005;
52
(9):
2645-55
-
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease.
Ho PP,
Fontoura P, Platten M, Sobel RA, DeVoss JJ, Lee LY, Kidd BA, Tomooka BH, Capers J, Agrawal A, Gupta R, Zernik J, Yee MK, Lee BJ, Garren H, Robinson WH, Steinman L.
J Immunol.
2005;
175
(9):
6226-34
-
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.
Platten M,
Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L.
Science.
2005;
310
(5749):
850-5
-
Microarray profiling of antiviral antibodies for the development of diagnostics, vaccines, and therapeutics.
Neuman de Vegvar HE,
Robinson WH.
Clin Immunol.
2004;
111
(2):
196-201
-
Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis.
Fontoura P,
Ho PP, DeVoss J, Zheng B, Lee BJ, Kidd BA, Garren H, Sobel RA, Robinson WH, Tessier-Lavigne M, Steinman L.
J Immunol.
2004;
173
(11):
6981-92
-
Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice.
Hueber W,
Zeng D, Sharpe O, Robinson WH, Strober S, Utz PJ.
Eur J Immunol.
2004;
34
(6):
1654-62
-
Unlocking the "PAD" lock on rheumatoid arthritis.
Utz PJ,
Genovese MC, Robinson WH.
Ann Rheum Dis.
2004;
63
(4):
330-2
-
High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases.
Graham KL,
Robinson WH, Steinman L, Utz PJ.
Autoimmunity.
2004;
37
(4):
269-72
-
Autoantibodies in early arthritis: advances in diagnosis and prognostication.
Hueber W,
Utz PJ, Robinson WH.
Clin Exp Rheumatol.
2003 Sep-Oct;
21
(5 Suppl 31):
S59-64
-
Genomic and proteomic analysis of multiple sclerosis. Opinion.
Robinson WH,
Utz PJ, Steinman L.
Curr Opin Immunol.
2003;
15
(6):
660-7
-
Protein arrays for autoantibody profiling and fine-specificity mapping.
Robinson WH,
Steinman L, Utz PJ.
Proteomics.
2003;
3
(11):
2077-84
-
Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen.
Neuman de Vegvar HE,
Amara RR, Steinman L, Utz PJ, Robinson HL, Robinson WH.
J Virol.
2003;
77
(20):
11125-38
-
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Robinson WH,
Fontoura P, Lee BJ, de Vegvar HE, Tom J, Pedotti R, DiGennaro CD, Mitchell DJ, Fong D, Ho PP, Ruiz PJ, Maverakis E, Stevens DB, Bernard CC, Martin R, Kuchroo VK, van Noort JM, Genain CP, Amor S, Olsson T, Utz PJ, Garren H, Steinman L.
Nat Biotechnol.
2003;
21
(9):
1033-9
-
Protein and peptide array analysis of autoimmune disease.
Robinson WH,
Steinman L, Utz PJ.
Biotechniques.
2002:
Suppl
66-9
-
Autoantigen microarrays for multiplex characterization of autoantibody responses.
Robinson WH,
DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, Fournel S, Fong D, Genovese MC, de Vegvar HE, Skriner K, Hirschberg DL, Morris RI, Muller S, Pruijn GJ, van Venrooij WJ, Smolen JS, Brown PO, Steinman L, Utz PJ.
Nat Med.
2002;
8
(3):
295-301
-
Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease.
Robinson WH,
Garren H, Utz PJ, Steinman L.
Clin Immunol.
2002;
103
(1):
7-12
-
Autoantibody profiling for the study and treatment of autoimmune disease.
Hueber W,
Utz PJ, Steinman L, Robinson WH.
Arthritis Res.
2002;
4
(5):
290-5
-
Proteomics technologies for the study of autoimmune disease.
Robinson WH,
Steinman L, Utz PJ.
Arthritis Rheum.
2002;
46
(4):
885-93
-
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Robinson WH,
Genovese MC, Moreland LW.
Arthritis Rheum.
2001;
44
(9):
1977-83
-
Allele-specific expression of the mouse B-cell surface protein CD72 on T cells.
Robinson WH,
Landolfi MM, Parnes JR.
Immunogenetics.
1997;
45
(3):
195-200
-
Structure of the mouse CD72 (Lyb-2) gene and its alternatively spliced transcripts.
Ying H,
Nakayama E, Robinson WH, Parnes JR.
J Immunol.
1995;
154
(6):
2743-52
-
Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
Robinson WH,
Neuman de Vegvar HE, Prohaska SS, Rhee JW, Parnes JR.
Eur J Immunol.
1995;
25
(10):
2765-9
-
Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH,
Prohaska SS, Santoro JC, Robinson HL, Parnes JR.
J Immunol.
1995;
155
(10):
4739-48
-
Biochemical identity of the mouse Ly-19.2 and Ly-32.2 alloantigens with the B cell differentiation antigen Lyb-2/CD72.
Robinson WH,
Landolfi MM, Schäfer H, Parnes JR.
J Immunol.
1993;
151
(9):
4764-72
-
Extensive polymorphism in the extracellular domain of the mouse B cell differentiation antigen Lyb-2/CD72.
Robinson WH,
Ying H, Miceli MC, Parnes JR.
J Immunol.
1992;
149
(3):
880-6
-
Synthesis of Viral-Specific Ribonucleic Acid in Rubella Virus-Infected Cells.
Wong KT,
Robinson WS, Merigan TC.
J Virol.
1969;
4
(6):
901-903
Navigation for This Section: Proteomics Center
Find a Researcher
Help